Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00865
|
|||||
| Drug Name |
Triazolam
|
|||||
| Synonyms |
8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine; 8-Chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine; 8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine; 8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine; 8-Chloro-6-[2-chlorophenyl]-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine; Alti-Triazolam; Apo Triazo; Apo-Triazo; Apo-Triazo (TN); Apotex Brand of Triazolam; Clorazolam; Gen Triazolam; Gen-Triazolam; Genpharm Brand of Triazolam; Gerard Brand of Triazolam; Halcion; Halcion (TN); Halcion (triazolam); Hypam (TN); Hypnostat; Novidorm; Novo-Triolam; Novodorm; Pfizer Brand of Triazolam; Songar; TGAR01H; Triazolam (JAN/USP/INN); Triazolam Pfizer Brand; Triazolam [USAN:BAN:INN:JAN]; Triazolamum; Triazolamum [INN-Latin]; Trilam; Trilam (TN); U 33,030; U 33030; U-33,030; U-33030; U33,030
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Hypnotics and Sedatives
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C17H12Cl2N4
|
|||||
| Canonical SMILES |
CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl
|
|||||
| InChI |
InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3
|
|||||
| InChIKey |
JOFWLTCLBGQGBO-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 28911-01-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 343.2 | Topological Polar Surface Area | 43.1 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
2.4
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:9674
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.